WednesdayAug 03, 2022 10:27 am

TinyGemsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Adds EV Technology Team Centrally Located to Motor City Resources

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today announced the addition of a new EV Technology team, focusing on developing EV technologies for Mullen’s portfolio of commercial vans. Located in Pontiac, Michigan, and centrally located to all automotive resources the Motor City Area has to offer, the team will be home to a new division of engineers and technology developers focused on Mullen’s Class 1 – 5 commercial vehicle development. The “Detroit Tech Center” and its team will play a critical role in Mullen’s goal of developing highly efficient EV technology that utilizes less energy consumption while…

Continue Reading

TuesdayAug 02, 2022 1:50 pm

TinyGemsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) Technology Helping Innovators of Today, Leaders of Tomorrow

Lexaria Bioscience Corp.’s (NASDAQ: LEXX) patented DehydraTECH(TM) has been regarded as one of the most innovative drug delivery technologies in years, proving useful in delivering a wide range of active pharmaceutical ingredients in a more palatable and effective way. Studies have also demonstrated DehydraTECH’s ability to increase bio-absorption with cannabinoids and nicotine by 5-10x and, in some instances, with cannabinoids by as much as 27x compared to standard industry formulations, a benefit that opens significant possibilities for important drug delivery. “DehydraTECH’s application in the cannabis sector is seeing a boom, particularly with the recent expansion of Boldt Runners Corporation, a…

Continue Reading

TuesdayAug 02, 2022 12:40 pm

TinyGemsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) CEO Spotlighted in Benzinga Live Interview

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, will be the topic of discussion in an upcoming Benzinga YouTube channel interview. The live interview, hosted by Zunaid Sulemanet and slated for Aug. 4, 2022, at 1:30 p.m. ET will feature Mullen CEO and chair David Michery. According to the announcement, Michery’s previous interviews with Benzinga have been some of its most popular events, with viewers from around the world watching the live one-on-one discussions. “I look forward to connecting with Benzinga later this week, especially after a recent health event that kept me away from the office for…

Continue Reading

TuesdayAug 02, 2022 12:20 pm

TinyGemsBreaks – Aditxt Inc. (NASDAQ: ADTX) Featured in Bell2Bell Podcast

Aditxt (NASDAQ: ADTX) was featured in the Bell2Bell Podcast, a part of IBN’s (InvestorBrandNetwork) sustained effort to provide specialized content distribution via widespread syndication channels. Amro Albanna, co-founder, chairman and CEO of Aditxt, joined the latest episode to provide an overview of the company and discuss its business model. “We are a biotech innovation company, and our focus is on immune diseases. The reality is that immune diseases are caused either by someone having too little immune response or too much immune response,” Albanna said. “When you have too little immune response and you’re dealing with COVID-19, we all understand…

Continue Reading

TuesdayAug 02, 2022 11:37 am

TinyGemsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Enters Joint Venture with Colombia’s Largest Indigenous Tribe

Flora (NASDAQ: FLGC) is a leading all-outdoor cultivator, manufacturer and distributor of global cannabis products and brands. The company today announced a joint venture agreement with Pharma Indigena Misak Manasr Sas (“Manasr”), the largest indigenous tribe in Colombia, on the development of cultivation best practices, manufacturing, export, and marketing of cannabis and cannabis containing products. “We are honored to be given opportunity to work hand-in-hand with the Misak people,” said Luis Merchan, Flora’s chairman and CEO. “Through this partnership, we will collaborate with the tribe on the processing and distribution of their Colombian-grown cannabis while offering Manasr a powerful platform…

Continue Reading

MondayAug 01, 2022 11:16 am

TinyGemsBreaks — Cepton Technologies Inc. (NASDAQ: CPTN) Names Industry Veteran as New COO

Cepton Technologies (NASDAQ: CPTN), a Silicon Valley innovator and leader in high-performance Micro Motion Technology(RM) (“MMT”) lidar solutions, has appointed Dr. Liqun Han as chief operating officer, a newly created role with responsibilities over the company’s product development and operations team. Han, a proven industry veteran, will continue to be in charge of the company’s flagship ADAS lidar program and will oversee and Cepton’s growing presence across automotive and smart infrastructure markets. Han joined Cepton in 2016 and has served as both vice president and senior vice president of operations, where he has led product development, commercialization and operational excellence teams;…

Continue Reading

MondayAug 01, 2022 11:03 am

TinyGemsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Opens New Automotive EV Development Center in California

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, has opened a new 16,000-square-foot automotive development center; the center is located in the center of the technology corridor of Irvine, California, and near the Irvine Spectrum Center. According to the announcement, as the company sees continued growth, it is strategically dividing its automotive teams between the new Irvine location and the existing MULN facility in Monrovia. The Irvine Automotive Development Center will house Mullen’s engineering design and development, styling, program management, marketing and finance teams, with Monrovia being home base for the company’s battery, powertrain, thermal and infotainment teams.…

Continue Reading

FridayJul 29, 2022 2:17 pm

TinyGemsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Leveraging Strategic Developments to Bring Its FIVE EV Crossover to Market

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, recently reported the results of its solid-state polymer battery testing. According to a recent article that contains excerpts from a Benzinga Brief, “Testing results from BIC [Battery Innovation Center] show the solid-state polymer cell, rated at 300 Ah and 3.7 volts, tested at 343.28 Ah at 4.2 volts, exceeding expectations, and is in line with test tolerance from previous EV Grid test results. The data supports solid-state polymer battery cell technology that, when scaled to the vehicle pack level and at a 150-kilowatt hour equivalent, can deliver over 600 miles…

Continue Reading

FridayJul 29, 2022 1:30 pm

TinyGemsBreaks – Golden Matrix Group Inc. (NASDAQ: GMGI) Looking to Capitalize on Booming iGaming, Esports Markets

Golden Matrix (NASDAQ: GMGI), a developer and licensor of online gaming platforms, systems and gaming content, intends to capitalize on the burgeoning iGaming market expected to reach $127 billion by 2025 from $76.8 billion in 2020, buoyed by growth in Europe, the U.S. and Asia. “Golden Matrix’s GM-X system and newly launched GMX-Ag platform are a gold standard for the iGaming market, delivering access to 10,000+ games from over 25 leading providers. More than 635 unique casino operations use Golden Matrix’s platform to serve more than 7 million registered users. The company made its entrance into the lucrative European markets…

Continue Reading

ThursdayJul 28, 2022 12:22 pm

TinyGemsBreaks – QSAM Biosciences Inc. (QSAM) Targeting Significant Unmet Medical Need with CycloSam(R)

QSAM Biosciences (OTCQB: QSAM) is a company developing a new class of drugs called radiopharmaceuticals that deliver radiation therapy directly and specifically to cancer cells. The company’s lead drug candidate, CycloSam(R), is a clinical-stage bone-seeking radiopharmaceutical designed to deliver targeted radiation safely and precisely to tumors in the bone. “QSAM is leading the charge to evaluate a new treatment for bone cancer and other related, underserved diseases. The company’s pioneering efforts are evident as the first patient has completed treatment in the company’s clinical trial designed to study the effect of its proprietary radiopharmaceutical technology: CycloSam(R),” a recent article reads.…

Continue Reading

Contact us: (512) 354-7000